2023-09-28 14:46:10 +00:00
|
|
|
abstract: 'Background: Funding is a significant barrier to employing general
|
|
|
|
|
|
|
|
|
|
practice pharmacists. Objective(s): To explore the feasibility of
|
|
|
|
|
|
|
|
|
|
determining the cost-benefit of pharmacists in Australian general
|
|
|
|
|
|
|
|
|
|
practice.
|
|
|
|
|
|
|
|
|
|
Methods: Two part-time pharmacists were employed by general practices in
|
|
|
|
|
|
|
|
|
|
Canberra, Australia. Diaries of the pharmacists were analysed to
|
|
|
|
|
|
|
|
|
|
determine time worked and participation in income-generating activities,
|
|
|
|
|
|
|
|
|
|
including Government-funded programs: Asthma Cycle of Care, Home
|
|
|
|
|
|
|
|
|
|
Medicine Reviews, and Health Care Assessments. Scenarios using different
|
|
|
|
|
|
|
|
|
|
practice and business models were entered into value-cost models to
|
|
|
|
|
|
|
|
|
|
determine the income generated by the pharmacists relative to their
|
|
|
|
|
|
|
|
|
|
salary.
|
|
|
|
|
|
|
|
|
|
Results: Over 19 weeks, pharmacists A and B supported 47 and 23 Asthma
|
|
|
|
|
|
|
|
|
|
Cycle of Care activities, generating income to the general practice of
|
|
|
|
|
|
|
|
|
|
AU\$4,700 and AU\$2,300, respectively. The pharmacists spent 36.4 and
|
|
|
|
|
|
|
|
|
|
24.1 hours on activities usually conducted by general practitioners
|
|
|
|
|
|
|
|
|
|
(GPs), allowing additional time for GP-patient consultations. Value-cost
|
|
|
|
|
|
|
|
|
|
models determined AU\$0.61 - AU\$1.20 income generation by pharmacists
|
|
|
|
|
|
|
|
|
|
per AU\$1 salary.
|
|
|
|
|
|
|
|
|
|
Conclusions: It was feasible to determine the value-cost ratios of
|
|
|
|
|
|
|
|
|
|
employing pharmacists in general practice using these methods. Future
|
|
|
|
|
|
|
|
|
|
work should focus on developing a robust business model that includes
|
|
|
|
|
|
|
|
|
|
health care system savings resulting from practice pharmacist
|
|
|
|
|
|
|
|
|
|
interventions, determined from randomised controlled trials.'
|
|
|
|
|
affiliation: 'Kosari, S (Corresponding Author), Univ Canberra, Fac Hlth, Discipline
|
|
|
|
|
Pharm, Canberra, ACT 2617, Australia.
|
|
|
|
|
|
|
|
|
|
Kosari, Sam; Deeks, Louise S.; Naunton, Mark; Tay, Guan Han; Peterson, Gregory M.,
|
|
|
|
|
Univ Canberra, Fac Hlth, Discipline Pharm, Canberra, ACT 2617, Australia.
|
|
|
|
|
|
|
|
|
|
Dawda, Paresh, Univ Canberra, Hlth Res Inst, Ctr Res \& Act Publ Hlth, Canberra,
|
|
|
|
|
ACT 2617, Australia.
|
|
|
|
|
|
|
|
|
|
Postma, Marteen J., Univ Groningen, Univ Med Ctr, Dept Hlth Sci, Pharm, Groningen,
|
|
|
|
|
Netherlands.
|
|
|
|
|
|
|
|
|
|
Peterson, Gregory M., Univ Tasmania, Fac Hlth, Hobart, Tas 7001, Australia.'
|
|
|
|
|
author: Kosari, Sam and Deeks, Louise S. and Naunton, Mark and Dawda, Paresh and Postma,
|
|
|
|
|
Marteen J. and Tay, Guan Han and Peterson, Gregory M.
|
|
|
|
|
author-email: sam.kosari@canberra.edu.au
|
|
|
|
|
author_list:
|
|
|
|
|
- family: Kosari
|
|
|
|
|
given: Sam
|
|
|
|
|
- family: Deeks
|
|
|
|
|
given: Louise S.
|
|
|
|
|
- family: Naunton
|
|
|
|
|
given: Mark
|
|
|
|
|
- family: Dawda
|
|
|
|
|
given: Paresh
|
|
|
|
|
- family: Postma
|
|
|
|
|
given: Marteen J.
|
|
|
|
|
- family: Tay
|
|
|
|
|
given: Guan Han
|
|
|
|
|
- family: Peterson
|
|
|
|
|
given: Gregory M.
|
|
|
|
|
da: '2023-09-28'
|
|
|
|
|
doi: 10.1016/j.sapharm.2020.07.030
|
|
|
|
|
earlyaccessdate: MAR 2021
|
|
|
|
|
eissn: 1934-8150
|
|
|
|
|
files: []
|
|
|
|
|
issn: 1551-7411
|
|
|
|
|
journal: RESEARCH IN SOCIAL \& ADMINISTRATIVE PHARMACY
|
|
|
|
|
keywords: 'Pharmacists; General practice; General practitioners; Primary care;
|
|
|
|
|
|
|
|
|
|
Economics'
|
|
|
|
|
language: English
|
|
|
|
|
month: MAY
|
|
|
|
|
number: '5'
|
|
|
|
|
number-of-cited-references: '29'
|
|
|
|
|
orcid-numbers: Postma, Maarten/0000-0002-6306-3653
|
|
|
|
|
pages: 1012-1016
|
|
|
|
|
papis_id: 8118f4a811d4ca3f83c73f7ef517ae95
|
|
|
|
|
ref: Kosari2021fundingpharmacists
|
|
|
|
|
times-cited: '3'
|
|
|
|
|
title: 'Funding pharmacists in general practice: A feasibility study to inform the
|
|
|
|
|
design of future economic evaluations'
|
2023-10-01 08:15:07 +00:00
|
|
|
type: article
|
2023-09-28 14:46:10 +00:00
|
|
|
unique-id: WOS:000633997800022
|
|
|
|
|
usage-count-last-180-days: '0'
|
|
|
|
|
usage-count-since-2013: '1'
|
|
|
|
|
volume: '17'
|
|
|
|
|
web-of-science-categories: Public, Environmental \& Occupational Health; Pharmacology
|
|
|
|
|
\& Pharmacy
|
|
|
|
|
year: '2021'
|
